NCT02656303 · Interventional trial
A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Overall registry status Terminated
Phase 2
Conditions Chronic Lymphocytic Leukemia
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory